This inventor holds 1 USPTO granted patent. Top assignee: Evolva Sa. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: David Pearson: Innovator in PPAR Modulation
Introduction
David Pearson is a notable inventor based in Royston, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate PPAR (Peroxisome Proliferator-Activated Receptor) activity. His work is crucial in addressing various diseases and conditions that rely on PPAR modulation.
Latest Patents
David Pearson holds 1 patent for his invention titled "Substituted 1,3-dioxanes useful as PPAR modulators." This patent describes specifically useful stereoisomers of 1,3-dioxane derivatives. These compounds are valuable in the treatment of diseases such as diabetes, cancer, inflammation, neurodegenerative disorders, and infections. Additionally, they are relevant in treating cardiovascular diseases related to TP (Thromboxane).
Career Highlights
David Pearson is currently associated with Evolva SA, a company focused on innovative solutions in the field of biotechnology. His work at Evolva has allowed him to explore and develop new therapeutic options that can significantly impact patient care.
Collaborations
David has collaborated with notable colleagues, including Peteris Alberts and Thierry Bonnaud. These partnerships have enhanced his research and development efforts, leading to advancements in the field.
Conclusion
David Pearson's innovative work in PPAR modulation exemplifies the impact of targeted research in addressing critical health issues. His contributions continue to pave the way for new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile